Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: March 2009
-
By Kevin E. Noonan — Genentech announced last week that the U.S. Patent and Trademark Office had determined it would issue a re-examination certificate in Re-examination Control No. 90/007,542 involving U.S. Patent No. 6,331,415 ("the Cabilly II patent"). While a major victory for Genentech, it represents a bitter defeat for Medimmune, Genentech's licensee, as…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. MedImmune, LLC v. Sun Pharmaceutical Industries Ltd. et al.1:09-cv-00452; filed February 24, 2009 in the District Court of Maryland Infringement of U.S.…
-
March 2-3, 2009 – 3rd Annual Patent Law Institute (Practising Law Institute) – New York, NY March 3, 2009 – Biotechnology, Chemical, and Pharmaceuticals (BCP) Technology Groups Customer Partnership Meeting (U.S. Patent & Trademark Office) – Alexandria, VA March 6, 2009 – "Riding the Wave: Understanding Recent Developments in IP Law" (Northwestern Journal of Technology…
Patent Docs 